Inventor · disambiguated record
Michael Thormann
Also filed as: THORMANN MICHAEL
17 granted patents·9 pending applications·55 citations·filing 2003–2025
90Inventor score
Top patents by PatentIndex Score
26 records- 0185US7741354B2Inhibitors of glutaminyl cyclasePROBIODRUG AG·Filed 2007·Granted Jun 22, 2010·11 cites·23 claims
- 0281US9802937B2Substituted pyrazolo{4,3-D}pyrimidines as kinase inhibitorsTHORMANN MICHAEL·Filed 2012·Granted Oct 31, 2017·9 cites·26 claims
- 0381US9155792B2RecA inhibitors with antibiotic activity, compositions and methods of useCOTTAREL GUILLAUME·Filed 2007·Granted Oct 13, 2015·16 cites·13 claims
- 0478US8889709B2Use of isoQC inhibitors in the treatment and prevention of inflammatory diseases or conditionsDEMUTH HANS-ULRICH·Filed 2009·Granted Nov 18, 2014·4 cites·37 claims
- 0573US7504436B2Bioisosteres of actinoninNOVARTIS AG·Filed 2004·Granted Mar 17, 2009·8 cites·9 claims
- 0669US10000482B2Kinase inhibitorsORIGENIS GMBH·Filed 2013·Granted Jun 19, 2018·2 cites·21 claims
- 0769US9637491B2Pyrazolo[4,3-D]pyrimidines as kinase inhibitorsORIGENIS GMBH·Filed 2013·Granted May 2, 2017·2 cites·26 claims
- 0867US9499535B2Kinase inhibitorsTHORMANN MICHAEL·Filed 2012·Granted Nov 22, 2016·2 cites·14 claims
- 0966US7932255B22-aminocarbonyl substituted piperazine or diaza-cyclic compounds as apoptosis protein inhibitors (lap) modulatorsNOVARTIS AG·Filed 2006·Granted Apr 26, 2011·1 cites·10 claims
- 1066US2025361237A11,4-dihydrobenzo[d]pyrazolo[3,4-f][1,3]diazepine derivatives and related compounds as lrrk2, nuak1 and/or tyk2 kinase modulators for the treatment of e.g. autoimmune diseaseORIGENIS GMBH·Filed 2025·Application pending·0 cites
- 1162US10752624B2Kinase inhibitorsORIGENIS GMBH·Filed 2018·Granted Aug 25, 2020·0 cites·7 claims
- 1256US12384788B21,4-dihydrobenzo[d]pyrazolo[3,4-f][1,3]diazepine derivatives and related compounds as LRRK2, NUAK1 and/or TYK2 kinase modulators for the treatment of e.g. autoimmune diseaseORIGENIS GMBH·Filed 2020·Granted Aug 12, 2025·0 cites·20 claims
- 1354US7728146B2Enzyme inhibitorsPROBIODRUG AG·Filed 2007·Granted Jun 1, 2010·0 cites·65 claims
- 1452US2025019382A1Novel inhibitors of cyclin-dependent kinasesORIGENIS GMBH·Filed 2022·Application pending·0 cites
- 1551US8962860B2Inhibitors of glutaminyl cyclaseHEISER ULRICH·Filed 2009·Granted Feb 24, 2015·0 cites·17 claims
- 1650US2024067655A1Kinase modulators and methods of use thereofNEURON23 INC·Filed 2021·Application pending·0 cites
- 1749US2025144105A1Cdk9 inhibitorsORIGENIS GMBH·Filed 2023·Application pending·0 cites
- 1847US7705037B21-substituted pyrrolidin-2-ones and use thereof as peptide deformylase inhibitorsNOVARTIS AG·Filed 2006·Granted Apr 27, 2010·0 cites·10 claims
- 1947US2023373985A1Kinase modulators and methods of use thereofORIGENIS GMBH·Filed 2021·Application pending·0 cites
- 2045US8420684B2Inhibitors of glutaminyl cyclaseTHORMANN MICHAEL·Filed 2007·Granted Apr 16, 2013·0 cites·23 claims
- 2145US8278345B2Inhibitors of glutaminyl cyclaseTHORMANN MICHAEL·Filed 2007·Granted Oct 2, 2012·0 cites·23 claims
- 2244US7662833B2Imidazo [1,2-A] pyridine derivatives useful as peptide deformylase (PDF) inhibitorsNOVARTIS AG·Filed 2006·Granted Feb 16, 2010·0 cites·20 claims
- 2344US2022380374A11,4-dihydrobenzo[d]pyrazolo[3,4-f][1,3]diazepine derivatives and related compounds as lrrk2, nuak1 and/or tyk2 kinase modulators for the treatment of e.g. autoimmune diseaseORIGENIS GMBH·Filed 2020·Application pending·0 cites
- 2442US2011183955A12-Aminocarbonyl Substituted Piperazine or Diaza-Cyclic Compounds as Apoptosis Protein Inhibitors (Iap) ModulatorsNOVARTIS AG·Filed 2011·Application pending·0 cites
- 2542US2010234397A1Enzyme inhibitorsPROBIODRUG AG·Filed 2010·Application pending·0 cites
- 2637US2005177280A1Methods and systems for discovery of chemical compounds and their synthesesMORPHOCHEM AG KOMB CHEMIE·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Thormann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →